NEW POST: Elon vs. RFK Jr.: Beyond the Drugs vs. Lifestyle Debate

An Integrative Medicine Perspective on America's Obesity Crisis

A recent New York Times article highlighted a stark divide between two of President-elect Trump's advisors on how to address America's obesity epidemic. While Elon Musk advocates for making GLP-1 inhibitors like Ozempic widely available at low cost, Robert F. Kennedy Jr. argues for prioritizing lifestyle changes as "the first line of response."

This debate perfectly illustrates the growing tension between pharmaceutical and lifestyle approaches to chronic health conditions. But as an integrative medicine physician, I believe this either/or framing misses the deeper complexity of the obesity crisis.